Quick Takeaways
- Redmile Group, LLC filed SCHEDULE 13G/A for Neurogene Inc. Common Stock, $0.000001 par value (NGNE).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
Redmile Group, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Neurogene Inc. Common Stock, $0.000001 par value (NGNE)
- Filing Manager
- Redmile Group, LLC
- Reporting Manager
- Redmile Group, LLC
- Symbol
- NGNE
- Shares outstanding
- 15,729,081 shares
- Disclosed Ownership
- 1,557,179 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:16:08 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Redmile Group, LLC disclosed 9.9% ownership in Neurogene Inc. Common Stock, $0.000001 par value (NGNE) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 17 Feb 2026, 16:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | 9.9% | 1,557,179 | 0 | 1,557,179 | /s/ Jeremy C. Green | Managing Member | |
| Jeremy C. Green | 9.9% | 1,557,179 | 0 | 1,557,179 | /s/ Jeremy C. Green | Jeremy C. Green | |
| Redmile Biopharma Investments I, L.P. | 4.8% | 749,610 | 0 | 749,610 | /s/ Jeremy C. Green | Managing Member of Redmile Group, LLC, Managing Member of Redmile Biopharma Investments I (GP), LLC, General Partner of Redmile Biopharma Investments |